One Year Drug Treatment in First-Episode Schizophrenia
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized, double-blind, multi-center study on 1 year course and treatment
outcome under low-dose typical (haloperidol) vs. atypical neuroleptics (risperidone) in
first-episode schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Collaborators:
German Federal Ministry of Education and Research German Research Network On Schizophrenia Humboldt-Universität zu Berlin Janssen-Cilag Ltd. Mainz University Martin-Luther-Universität Halle-Wittenberg RWTH Aachen University Universität Duisburg-Essen University Hospital Tuebingen University of Bonn University of Cologne University of Göttingen University of Jena University of Mannheim University of München University of Wuerzburg